Catalyst Biosciences

$6.22
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.25 (-3.86%) Today
$0.00 (0.00%) As of 4:00 PM EDT after-hours

Why Robinhood?

You can buy or sell CBIO and other stocks, options, ETFs, and crypto commission-free!

About CBIO

Catalyst Biosciences, Inc. Common Stock, also called Catalyst Biosciences, is a clinical-stage biopharmaceutical company, which engages in the development of novel medicines to address serious medical conditions. Read More Its pipeline includes hemostasis such as Factor VIIa marzeptacog alfa, Factor IX dalcinonacog alfa, and Factor Xa; and anti-complement. The company was founded on August 20, 2015 and is headquartered in South San Francisco, CA.

Employees
21
Headquarters
South San Francisco, California
Founded
2015
Market Cap
77.74M
Price-Earnings Ratio
Dividend Yield
Average Volume
59.17K
High Today
$6.53
Low Today
$6.22
Open Price
$6.50
Volume
77.83K
52 Week High
$11.44
52 Week Low
$6.01

Collections

CBIO Earnings

-$1.53
-$1.20
-$0.87
-$0.54
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Estimated
Actual
Expected Oct 31, Pre-Market
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.